The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 20.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (16 analysts) rates it buy, with a mean price target of $21.
Albertsons Companies, Inc.
ACI · the NYSE · USD · Market cap $6.1B · 106,400 employees
Albertsons Companies, Inc., through its subsidiaries, operates in the food and drug retail industry in the United States.
FAIL · Does not pass the screenAt the last full screen
2026-09-16
Screened 2026-09-16 · the tape above runs as of 23:00 UTC · 18 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Albertsons Companies, Inc. holds its Markup at $12.56. The statistical read favours the buyers, held for 15 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 15 days |
| Price at the screen | $12.56 |
| Valuation | 78.50 trailing · 6.79 forward price to earnings |
| Values screen | FAIL · score 64.7 |
| Beta | 0.20 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 57.15% | Below 33% | Interest-bearing debt is 57.2% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 4.23% | Below 49% | Money owed to the company is 4.2% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.01% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. A 29.4% margin of safety to the base estimate.
Third-party analyst targets: 16 covering, consensus Hold. The average target sits +4% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSupermarket shelves stocked but the till stays empty
Every week shoppers fill their trolleys with milk, bread and prescriptions, yet Albertsons turns none of that into profit. Revenue is rising 8 percent, the forward multiple sits at just 6.2 times, and our fair-value estimate is $25 against the current $15 price. None of that matters when the profit margin prints at zero and return on equity reaches only 8 percent. We pass.
The business model looks defensive on paper, groceries and pharmacies never go away. Still, the lack of earnings leaves no cushion for higher wages, fuel costs or any fresh price war with bigger rivals. Analysts see a buy and point to $20, but zero bottom-line delivery turns the low multiple into a warning rather than a bargain.
Currency moves and labour contracts add further pressure in a sector already known for thin returns. Ethical screen clears, yet the numbers show no durable edge worth backing today. Analysis, not advice.
| Forward P/E | 6.8xexpensive even after accounting for its growth |
| Trailing P/E | 78.5xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.16 |
| EPS, forward | 1.85 |
| Revenue growth | +0.2%slow but positive growth |
| Profit margin | 0.1%barely profitable |
| Return on equity | 2.7%a modest return on shareholder capital |
| FCF yield | 28.76% |
| Dividend yield | 424.00% |
| Debt to equity | 9.74heavy leverage: higher risk if revenue softens |
| Current ratio | 0.84below 1: short-term bills exceed liquid assets |
| Beta | 0.20barely tracks the market's swings |
| Short interest, float | 0.17% |
| 52-week range | 10.86 - 20.00 |
| Market cap | $6.1B |
| Employees | 106,400 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeACI trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (16 analysts) rates it buy, with a mean price target of $21.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (16 analysts) rates it buy, with a mean price target of $21.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (65). The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (16 analysts) rates it buy, with a mean price target of $21.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (65). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (65). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-24 | Kevin Hern | Republican | buy | 100K–250K |
| 2026-08-24 | Kevin Hern | Republican | buy | 100K–250K |
| 2026-08-24 | Kevin Hern | Republican | buy | 100K–250K |
| 2026-08-24 | Kevin Hern | Republican | buy | 100K–250K |
| 2026-08-19 | Gil Cisneros | Democrat | buy | 250K–500K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.92 | -3.4% | · | $966 | -3.4% |
| 2 months | $17.11 | -10.1% | $0.17 | $909 | -9.1% |
| 3 months | $16.70 | -7.9% | $0.17 | $931 | -6.9% |
| 6 months | $16.96 | -9.3% | $0.32 | $926 | -7.4% |
| 1 year | $20.50 | -25.0% | $0.62 | $780 | -22.0% |
| 2 years | $18.86 | -18.5% | $1.16 | $877 | -12.3% |
| 3 years | $19.15 | -19.7% | $1.64 | $889 | -11.1% |
| 5 years | $13.56 | +13.4% | $9.43 | $1,830 | +83.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ACI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.